We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MORNING UPDATE: Man Securities Issues Alerts for AMAT, BGEN, SCMR, VXGN, And CERN CHICAGO, Nov. 13 /PRNewswire/ -- Man Securities issues the following Morning Update at 8:30 AM EST with new...
Biogen und IDEC Pharmaceuticals schliessen Fusion zur Schaffung neuen f?hrenden Biotechnologieunternehmens ab CAMBRIDGE, Massachusetts, und SAN DIEGO, November 13 /PRNewswire/ -- Die IDEC...
Biogen e IDEC Pharmaceuticals completan su fusi?n y crean un nuevo l?der biotecnol?gico CAMBRIDGE, Massachusetts, November 13 /PRNewswire/ -- IDEC Pharmaceuticals Corporation y Biogen Inc. han...
Biogen et IDEC Pharmaceuticals ont conclu une fusion qui donne naissance ? un nouveau chef de file de l'industrie biotechnologique CAMBRIDGE, Massachusetts et SAN DIEGO, November 13 /PRNewswire/...
Biogen and IDEC Pharmaceuticals Complete Merger to Create New Biotechnology Industry Leader CAMBRIDGE, Massachusetts and SAN DIEGO, November 13 /PRNewswire/ -- IDEC Pharmaceuticals Corporation and...
Biogen and IDEC Pharmaceuticals Complete Merger to Create New Biotechnology Industry Leader CAMBRIDGE, Mass., and SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- IDEC Pharmaceuticals Corporation...
Biogen and IDEC Pharmaceuticals to Make Presentation at Credit Suisse First Boston Healthcare Conference CAMBRIDGE, Mass., and SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Biogen, Inc. and IDEC...
Biogen anuncia los resultados de los ensayos de fase II con ADENTRI CAMBRIDGE, Massachusetts, November 10 /PRNewswire/ -- Biogen (Nasdaq: BGEN) ha anunciado hoy los resultados positivos de...
Biogen Announces Results of Phase II Trials With ADENTRI at American Heart Association Meeting CAMBRIDGE, Mass., November 10 /PRNewswire/ -- Biogen (Nasdaq: BGEN) today announced positive results...
Biogen Announces Results of Phase II Trials With ADENTRI(TM) at American Heart Association Meeting CAMBRIDGE, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Biogen today announced positive results of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions